EC Communication (part 1): How to address critical medicines shortages
by Giuliana Miglierini As announced on 3 October in the speech given by Commissioner Stella Kyriakides at European…
EMA’s reflection paper on AI in the pharmaceutical lifecycle
by Giuliana Miglierini The rapidly evolving role of artificial intelligence (AI) and its possible application in the pharmaceutical…
The New Pharmaceutical Legislation
by Jane Nicholson To celebrate the 70th Anniversary of the foundation of the Belgian Association of Industrial Pharmacists…
EMA’s 3-year work plan for the Quality domain
by Giuliana Miglierini The European Medicines Agency has released the input notes made by the GMDP Inspectors Working…
EMA’s recommendations to prevent medicines shortages
By Giuliana Miglierini Continuity of medicinal product supply is still representing a key issue for European countries. The…
EMA, new features for the PRIority Medicines (PRIME) scheme
By Giuliana Miglierini Based on the review of results obtained in the first five years of implementation of…